ERPD-Round 11-2019: Diagnostic tests concerning Malaria, G6PD deficiency and Syphilis infections

Information for manufacturers:

Dear all,

The Global Fund and Unitaid are inviting manufacturers of diagnostic products to submit an expression of interest to have their products evaluated by the Expert Review Panel for Diagnostics (EPRD). This evaluation will focus particularly on diagnostic products addressing Malaria, G6PD deficiency and Syphilis infections. Detailed information about the review process and submission requirements can be found in the document below.

Once all expressions of interest have been received, the EPRD will determine which products they will wish to evaluate.

Deadline for submission of an expression of interest is 15 April 2019. The results of the product evaluations are expected to be released in Q3 2019.

Please, see below the website link with the invitation to manufacturers to submit an Expression of Interest for ERPD evaluation:

https://www.theglobalfund.org/en/sourcing-management/updates/2019-02-15-opportunity-for-evaluation-of-diagnostic-products/

Please forward the message to all contacts at manufacturers or other institutions you feel necessary.

Best regards
René Becker-Burgos

René Becker Burgos, PhD
Specialist, Diagnostic Products Quality Assurance
The Global Fund to Fight AIDS, Tuberculosis and Malaria
Global Health Campus | Chemin du Pommier 40 | CH-1218 Grand-Saconnex - Geneva, Switzerland
Phone: +41 58 791 1700 | Mobile: +41 79 412 1254
Email: [rene.becker-burgos@theglobalfund.org] | Web: [www.theglobalfund.org]